Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Buy
61
GTHP Quote, Financials, Valuation and Earnings
Last price:
$0.32
Seasonality move
:
-8.93%
Day range:
$0.31 - $0.32
52-week range:
$0.06 - $0.32
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
130.49x
P/B ratio:
--
Volume:
31.8K
Avg. volume:
8K
1-year change:
97.53%
Market cap:
$26.8M
Revenue:
$7K
EPS (TTM):
-$0.04
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
GTHP
Guided Therapeutics, Inc.
|
-- | -- | -- | -- | -- |
|
ELMD
Electromed, Inc.
|
$16.6M | -- | 11.04% | -- | $36.00 |
|
IRIX
IRIDEX Corp.
|
$12.8M | -$0.12 | -2.72% | -18.18% | -- |
|
MYO
Myomo, Inc.
|
$9.4M | -$0.11 | -13.8% | -1168.66% | $5.00 |
|
PAHC
Phibro Animal Health Corp.
|
$345.4M | $0.60 | 15% | 756.68% | $43.00 |
|
STXS
Stereotaxis, Inc.
|
$8.4M | -$0.06 | 43.53% | -30.79% | $4.20 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
GTHP
Guided Therapeutics, Inc.
|
$0.32 | -- | $26.8M | -- | $0.00 | 0% | 130.49x |
|
ELMD
Electromed, Inc.
|
$29.93 | $36.00 | $249.6M | 32.20x | $0.00 | 0% | 3.99x |
|
IRIX
IRIDEX Corp.
|
$0.97 | -- | $16.7M | -- | $0.00 | 0% | 0.32x |
|
MYO
Myomo, Inc.
|
$0.90 | $5.00 | $34.6M | -- | $0.00 | 0% | 0.89x |
|
PAHC
Phibro Animal Health Corp.
|
$40.41 | $43.00 | $1.6B | 24.30x | $0.12 | 1.19% | 1.18x |
|
STXS
Stereotaxis, Inc.
|
$2.32 | $4.20 | $216.5M | -- | $0.00 | 0% | 6.84x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
GTHP
Guided Therapeutics, Inc.
|
-74.91% | 5.088 | 11.94% | 0.01x |
|
ELMD
Electromed, Inc.
|
-- | 1.217 | -- | 4.58x |
|
IRIX
IRIDEX Corp.
|
50.55% | 0.834 | 18.81% | 1.03x |
|
MYO
Myomo, Inc.
|
45.68% | -2.855 | 35.87% | 1.94x |
|
PAHC
Phibro Animal Health Corp.
|
71.58% | 2.736 | 47.87% | 1.12x |
|
STXS
Stereotaxis, Inc.
|
32.62% | 1.831 | 1.93% | 0.81x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
GTHP
Guided Therapeutics, Inc.
|
$8K | -$485K | -- | -- | -808.33% | -$279K |
|
ELMD
Electromed, Inc.
|
$13.2M | $2.7M | 18.88% | 18.89% | 15.81% | -$98K |
|
IRIX
IRIDEX Corp.
|
$4M | -$1.4M | -54.1% | -155.93% | -11.3% | -$1.2M |
|
MYO
Myomo, Inc.
|
$6.4M | -$3.5M | -46.49% | -68.35% | -34.86% | -$2.9M |
|
PAHC
Phibro Animal Health Corp.
|
$119.3M | $47.9M | 6.8% | 24.77% | 13.16% | -$4.5M |
|
STXS
Stereotaxis, Inc.
|
$4.1M | -$5.2M | -141.59% | -218.3% | -69.75% | -$4.2M |
Guided Therapeutics, Inc. vs. Competitors
-
Which has Higher Returns GTHP or ELMD?
Electromed, Inc. has a net margin of -1236.67% compared to Guided Therapeutics, Inc.'s net margin of 12.65%. Guided Therapeutics, Inc.'s return on equity of -- beat Electromed, Inc.'s return on equity of 18.89%.
Company Gross Margin Earnings Per Share Invested Capital GTHPGuided Therapeutics, Inc.13.33% -$0.01 -$3.2M ELMDElectromed, Inc.78.15% $0.25 $44.7M -
What do Analysts Say About GTHP or ELMD?
Guided Therapeutics, Inc. has a consensus price target of --, signalling upside risk potential of 34999900%. On the other hand Electromed, Inc. has an analysts' consensus of $36.00 which suggests that it could grow by 20.28%. Given that Guided Therapeutics, Inc. has higher upside potential than Electromed, Inc., analysts believe Guided Therapeutics, Inc. is more attractive than Electromed, Inc..
Company Buy Ratings Hold Ratings Sell Ratings GTHPGuided Therapeutics, Inc.0 0 0 ELMDElectromed, Inc.4 0 0 -
Is GTHP or ELMD More Risky?
Guided Therapeutics, Inc. has a beta of 0.639, which suggesting that the stock is 36.117% less volatile than S&P 500. In comparison Electromed, Inc. has a beta of 0.259, suggesting its less volatile than the S&P 500 by 74.113%.
-
Which is a Better Dividend Stock GTHP or ELMD?
Guided Therapeutics, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Electromed, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Guided Therapeutics, Inc. pays -- of its earnings as a dividend. Electromed, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GTHP or ELMD?
Guided Therapeutics, Inc. quarterly revenues are $60K, which are smaller than Electromed, Inc. quarterly revenues of $16.9M. Guided Therapeutics, Inc.'s net income of -$742K is lower than Electromed, Inc.'s net income of $2.1M. Notably, Guided Therapeutics, Inc.'s price-to-earnings ratio is -- while Electromed, Inc.'s PE ratio is 32.20x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Guided Therapeutics, Inc. is 130.49x versus 3.99x for Electromed, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GTHPGuided Therapeutics, Inc.130.49x -- $60K -$742K ELMDElectromed, Inc.3.99x 32.20x $16.9M $2.1M
-
Which has Higher Returns GTHP or IRIX?
IRIDEX Corp. has a net margin of -1236.67% compared to Guided Therapeutics, Inc.'s net margin of -12.6%. Guided Therapeutics, Inc.'s return on equity of -- beat IRIDEX Corp.'s return on equity of -155.93%.
Company Gross Margin Earnings Per Share Invested Capital GTHPGuided Therapeutics, Inc.13.33% -$0.01 -$3.2M IRIXIRIDEX Corp.32.15% -$0.09 $9.5M -
What do Analysts Say About GTHP or IRIX?
Guided Therapeutics, Inc. has a consensus price target of --, signalling upside risk potential of 34999900%. On the other hand IRIDEX Corp. has an analysts' consensus of -- which suggests that it could grow by 106.19%. Given that Guided Therapeutics, Inc. has higher upside potential than IRIDEX Corp., analysts believe Guided Therapeutics, Inc. is more attractive than IRIDEX Corp..
Company Buy Ratings Hold Ratings Sell Ratings GTHPGuided Therapeutics, Inc.0 0 0 IRIXIRIDEX Corp.0 0 0 -
Is GTHP or IRIX More Risky?
Guided Therapeutics, Inc. has a beta of 0.639, which suggesting that the stock is 36.117% less volatile than S&P 500. In comparison IRIDEX Corp. has a beta of 0.652, suggesting its less volatile than the S&P 500 by 34.842%.
-
Which is a Better Dividend Stock GTHP or IRIX?
Guided Therapeutics, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IRIDEX Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Guided Therapeutics, Inc. pays -- of its earnings as a dividend. IRIDEX Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GTHP or IRIX?
Guided Therapeutics, Inc. quarterly revenues are $60K, which are smaller than IRIDEX Corp. quarterly revenues of $12.5M. Guided Therapeutics, Inc.'s net income of -$742K is higher than IRIDEX Corp.'s net income of -$1.6M. Notably, Guided Therapeutics, Inc.'s price-to-earnings ratio is -- while IRIDEX Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Guided Therapeutics, Inc. is 130.49x versus 0.32x for IRIDEX Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GTHPGuided Therapeutics, Inc.130.49x -- $60K -$742K IRIXIRIDEX Corp.0.32x -- $12.5M -$1.6M
-
Which has Higher Returns GTHP or MYO?
Myomo, Inc. has a net margin of -1236.67% compared to Guided Therapeutics, Inc.'s net margin of -36.3%. Guided Therapeutics, Inc.'s return on equity of -- beat Myomo, Inc.'s return on equity of -68.35%.
Company Gross Margin Earnings Per Share Invested Capital GTHPGuided Therapeutics, Inc.13.33% -$0.01 -$3.2M MYOMyomo, Inc.63.84% -$0.09 $26.9M -
What do Analysts Say About GTHP or MYO?
Guided Therapeutics, Inc. has a consensus price target of --, signalling upside risk potential of 34999900%. On the other hand Myomo, Inc. has an analysts' consensus of $5.00 which suggests that it could grow by 454.94%. Given that Guided Therapeutics, Inc. has higher upside potential than Myomo, Inc., analysts believe Guided Therapeutics, Inc. is more attractive than Myomo, Inc..
Company Buy Ratings Hold Ratings Sell Ratings GTHPGuided Therapeutics, Inc.0 0 0 MYOMyomo, Inc.4 0 0 -
Is GTHP or MYO More Risky?
Guided Therapeutics, Inc. has a beta of 0.639, which suggesting that the stock is 36.117% less volatile than S&P 500. In comparison Myomo, Inc. has a beta of 1.026, suggesting its more volatile than the S&P 500 by 2.583%.
-
Which is a Better Dividend Stock GTHP or MYO?
Guided Therapeutics, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Myomo, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Guided Therapeutics, Inc. pays -- of its earnings as a dividend. Myomo, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GTHP or MYO?
Guided Therapeutics, Inc. quarterly revenues are $60K, which are smaller than Myomo, Inc. quarterly revenues of $10.1M. Guided Therapeutics, Inc.'s net income of -$742K is higher than Myomo, Inc.'s net income of -$3.7M. Notably, Guided Therapeutics, Inc.'s price-to-earnings ratio is -- while Myomo, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Guided Therapeutics, Inc. is 130.49x versus 0.89x for Myomo, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GTHPGuided Therapeutics, Inc.130.49x -- $60K -$742K MYOMyomo, Inc.0.89x -- $10.1M -$3.7M
-
Which has Higher Returns GTHP or PAHC?
Phibro Animal Health Corp. has a net margin of -1236.67% compared to Guided Therapeutics, Inc.'s net margin of 7.29%. Guided Therapeutics, Inc.'s return on equity of -- beat Phibro Animal Health Corp.'s return on equity of 24.77%.
Company Gross Margin Earnings Per Share Invested Capital GTHPGuided Therapeutics, Inc.13.33% -$0.01 -$3.2M PAHCPhibro Animal Health Corp.32.8% $0.65 $1.1B -
What do Analysts Say About GTHP or PAHC?
Guided Therapeutics, Inc. has a consensus price target of --, signalling upside risk potential of 34999900%. On the other hand Phibro Animal Health Corp. has an analysts' consensus of $43.00 which suggests that it could grow by 6.41%. Given that Guided Therapeutics, Inc. has higher upside potential than Phibro Animal Health Corp., analysts believe Guided Therapeutics, Inc. is more attractive than Phibro Animal Health Corp..
Company Buy Ratings Hold Ratings Sell Ratings GTHPGuided Therapeutics, Inc.0 0 0 PAHCPhibro Animal Health Corp.0 2 0 -
Is GTHP or PAHC More Risky?
Guided Therapeutics, Inc. has a beta of 0.639, which suggesting that the stock is 36.117% less volatile than S&P 500. In comparison Phibro Animal Health Corp. has a beta of 0.771, suggesting its less volatile than the S&P 500 by 22.868%.
-
Which is a Better Dividend Stock GTHP or PAHC?
Guided Therapeutics, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Phibro Animal Health Corp. offers a yield of 1.19% to investors and pays a quarterly dividend of $0.12 per share. Guided Therapeutics, Inc. pays -- of its earnings as a dividend. Phibro Animal Health Corp. pays out 40.46% of its earnings as a dividend. Phibro Animal Health Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios GTHP or PAHC?
Guided Therapeutics, Inc. quarterly revenues are $60K, which are smaller than Phibro Animal Health Corp. quarterly revenues of $363.9M. Guided Therapeutics, Inc.'s net income of -$742K is lower than Phibro Animal Health Corp.'s net income of $26.5M. Notably, Guided Therapeutics, Inc.'s price-to-earnings ratio is -- while Phibro Animal Health Corp.'s PE ratio is 24.30x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Guided Therapeutics, Inc. is 130.49x versus 1.18x for Phibro Animal Health Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GTHPGuided Therapeutics, Inc.130.49x -- $60K -$742K PAHCPhibro Animal Health Corp.1.18x 24.30x $363.9M $26.5M
-
Which has Higher Returns GTHP or STXS?
Stereotaxis, Inc. has a net margin of -1236.67% compared to Guided Therapeutics, Inc.'s net margin of -86.59%. Guided Therapeutics, Inc.'s return on equity of -- beat Stereotaxis, Inc.'s return on equity of -218.3%.
Company Gross Margin Earnings Per Share Invested Capital GTHPGuided Therapeutics, Inc.13.33% -$0.01 -$3.2M STXSStereotaxis, Inc.54.94% -$0.07 $17.1M -
What do Analysts Say About GTHP or STXS?
Guided Therapeutics, Inc. has a consensus price target of --, signalling upside risk potential of 34999900%. On the other hand Stereotaxis, Inc. has an analysts' consensus of $4.20 which suggests that it could grow by 81.04%. Given that Guided Therapeutics, Inc. has higher upside potential than Stereotaxis, Inc., analysts believe Guided Therapeutics, Inc. is more attractive than Stereotaxis, Inc..
Company Buy Ratings Hold Ratings Sell Ratings GTHPGuided Therapeutics, Inc.0 0 0 STXSStereotaxis, Inc.3 0 0 -
Is GTHP or STXS More Risky?
Guided Therapeutics, Inc. has a beta of 0.639, which suggesting that the stock is 36.117% less volatile than S&P 500. In comparison Stereotaxis, Inc. has a beta of 1.472, suggesting its more volatile than the S&P 500 by 47.244%.
-
Which is a Better Dividend Stock GTHP or STXS?
Guided Therapeutics, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Stereotaxis, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Guided Therapeutics, Inc. pays -- of its earnings as a dividend. Stereotaxis, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GTHP or STXS?
Guided Therapeutics, Inc. quarterly revenues are $60K, which are smaller than Stereotaxis, Inc. quarterly revenues of $7.5M. Guided Therapeutics, Inc.'s net income of -$742K is higher than Stereotaxis, Inc.'s net income of -$6.5M. Notably, Guided Therapeutics, Inc.'s price-to-earnings ratio is -- while Stereotaxis, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Guided Therapeutics, Inc. is 130.49x versus 6.84x for Stereotaxis, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GTHPGuided Therapeutics, Inc.130.49x -- $60K -$742K STXSStereotaxis, Inc.6.84x -- $7.5M -$6.5M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Sell
49
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
55
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
35
SMX alert for Dec 19
SMX (Security Matters) Plc [SMX] is up 24.85% over the past day.
Sell
36
INSP alert for Dec 19
Inspire Medical Systems, Inc. [INSP] is down 19.66% over the past day.
Sell
40
INSM alert for Dec 19
Insmed, Inc. [INSM] is down 16.08% over the past day.
